SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-045921
Filing Date
2020-08-10
Accepted
2020-08-10 16:03:09
Documents
1
Period of Report
2020-08-05

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8231
  Complete submission text file 0001209191-20-045921.txt   9625
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Sandercock Colin (Reporting) CIK: 0001724870 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38327 | Film No.: 201089281